STOCK TITAN

Florida Oncology and Hematology and American Oncology Network Opens New Location in Cape Coral, Welcomes Medical Director, Dr. Van den Bergh, and Drs. Venkata Parsa, and Shivtaj Mann

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Florida Oncology and Hematology, a partner practice of American Oncology Network (AON) (OTCQX: AONC), has opened a new location in Cape Coral, Florida. The clinic, located at 326 Del Prado Blvd, Suite 301, welcomes three board-certified medical oncologists: Dr. Magali Van den Bergh (Medical Director), Dr. Venkata Parsa, and Dr. Shivtaj Mann.

The new facility offers comprehensive cancer care services, including an on-site infusion room, in-house lab and pathology services, access to an in-house specialty pharmacy, and support with care coordination and financial counseling. This expansion marks Florida Oncology and Hematology's fifth location in Florida since August 2024, demonstrating the practice's commitment to providing community-based, patient-centered oncology care.

Florida Oncology e Ematologia, una pratica partner di American Oncology Network (AON) (OTCQX: AONC), ha aperto una nuova sede a Cape Coral, Florida. La clinica, situata al 326 Del Prado Blvd, Suite 301, accoglie tre oncologi medici certificati: Dr. Magali Van den Bergh (Direttore Medico), Dr. Venkata Parsa e Dr. Shivtaj Mann.

La nuova struttura offre servizi completi di assistenza oncologica, inclusa una sala per infusioni in loco, servizi di laboratorio e patologia interni, accesso a una farmacia specialistica interna e supporto per la coordinazione dell'assistenza e consulenze finanziarie. Questa espansione segna la quinta sede di Florida Oncology e Ematologia in Florida dal agosto 2024, dimostrando l'impegno della pratica a fornire cure oncologiche centrati sulla comunità e sui pazienti.

Florida Oncología y Hematología, una práctica asociada a American Oncology Network (AON) (OTCQX: AONC), ha abierto una nueva ubicación en Cape Coral, Florida. La clínica, ubicada en 326 Del Prado Blvd, Suite 301, recibe a tres oncólogos médicos certificados: Dr. Magali Van den Bergh (Directora Médica), Dr. Venkata Parsa y Dr. Shivtaj Mann.

La nueva instalación ofrece servicios integrales de atención oncológica, que incluyen una sala de infusión en el lugar, servicios de laboratorio y patología internos, acceso a una farmacia de especialidad interna y apoyo con la coordinación de la atención y asesoramiento financiero. Esta expansión marca la quinta ubicación de Florida Oncología y Hematología en Florida desde agosto de 2024, demostrando el compromiso de la práctica de proporcionar atención oncológica centrada en la comunidad y en el paciente.

플로리다 종양학 및 혈액학미국 종양학 네트워크(AON)의 파트너 병원(OTCQX: AONC)으로서 플로리다 케이프 코랄에 새로운 지점을 개설했습니다. 이 클리닉은 326 Del Prado Blvd, Suite 301에 위치하고 있으며, 세 명의 의료 종양학 인증 의사를 환영합니다: Dr. Magali Van den Bergh (의료 이사), Dr. Venkata Parsa, Dr. Shivtaj Mann입니다.

이 새로운 시설은 현장 주사실, 내부 실험실 및 병리 서비스, 내부 전문 약국 접근, 치료 조정 및 재정 상담 지원을 포함한 종합 암 치료 서비스를 제공합니다. 이번 확장은 2024년 8월 이후 플로리다 종양학 및 혈액학의 다섯 번째 위치를 차지하게 되며, 지역사회 중심의 환자 중심 암 치료를 제공하려는 이 병원의 헌신을 보여줍니다.

Oncologie et Hématologie de Floride, un cabinet partenaire de American Oncology Network (AON) (OTCQX: AONC), a ouvert un nouveau site à Cape Coral, en Floride. La clinique, située au 326 Del Prado Blvd, Suite 301, accueille trois oncologues médicaux certifiés : Dr. Magali Van den Bergh (Directrice Médicale), Dr. Venkata Parsa et Dr. Shivtaj Mann.

La nouvelle installation offre des services complets de soins du cancer, y compris une salle d'infusion sur place, des services de laboratoire et de pathologie internes, un accès à une pharmacie spécialisée interne et un soutien pour la coordination des soins et le conseil financier. Cette expansion marque le cinquième site d'Oncologie et Hématologie de Floride depuis août 2024, soulignant l'engagement de la pratique à fournir des soins oncologiques centrés sur la communauté et le patient.

Florida Onkologie und Hämatologie, eine Partnerpraxis von American Oncology Network (AON) (OTCQX: AONC), hat einen neuen Standort in Cape Coral, Florida, eröffnet. Die Klinik befindet sich in der 326 Del Prado Blvd, Suite 301, und begrüßt drei zertifizierte Fachärzte für Innere Medizin: Dr. Magali Van den Bergh (Medizinische Direktorin), Dr. Venkata Parsa und Dr. Shivtaj Mann.

Die neue Einrichtung bietet umfassende Krebsversorgungsdienste an, darunter einen Infusionsraum vor Ort, interne Labor- und Pathologiedienste, Zugang zu einer internen Spezialapotheke sowie Unterstützung bei der Koordination der Behandlung und finanzieller Beratung. Diese Expansion markiert den fünften Standort von Florida Onkologie und Hämatologie in Florida seit August 2024 und zeigt das Engagement der Praxis, gemeinschaftsbasierte, patientenzentrierte Onkologiepflege bereitzustellen.

Positive
  • Expansion of Florida Oncology and Hematology with a new location in Cape Coral
  • Addition of three board-certified medical oncologists to the team
  • Comprehensive on-site services including infusion, lab, and pharmacy
  • Rapid growth with five new locations opened since August 2024
Negative
  • None.

Insights

The opening of a new Florida Oncology and Hematology location in Cape Coral, in partnership with American Oncology Network (AON), represents a strategic expansion in community oncology services. This move aligns with the growing trend of providing accessible, high-quality cancer care outside of major urban centers.

The addition of three board-certified medical oncologists enhances the practice's capabilities and potentially increases patient volume. However, the immediate financial impact on AON (OTCQX: AONC) may be , given its $17 million market cap. The expansion could contribute to long-term growth but is unlikely to significantly affect short-term financials.

Investors should note that this expansion demonstrates AON's commitment to its community-based care model, which could be a differentiator in the competitive oncology market. The focus on comprehensive services, including on-site infusion and in-house labs, may improve patient retention and potentially lead to better margins over time.

The integration of Drs. Van den Bergh, Parsa and Mann into the Florida Oncology and Hematology team brings a wealth of expertise to the Cape Coral location. Their triple board certifications and diverse training backgrounds suggest a high standard of care that could attract patients and referrals.

The practice's comprehensive offering, including access to clinical trials and survivorship programs, positions it as a one-stop shop for cancer care. This integrated approach can lead to better patient outcomes and potentially reduce overall healthcare costs, which is increasingly important in value-based care models.

While the immediate impact on patient volumes is not quantified, the expansion into Cape Coral addresses a growing need for oncology services in Florida's aging population. The community-based model may resonate well with patients seeking personalized care close to home, potentially driving patient satisfaction and loyalty.

Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO join the Cape Coral physician team

CAPE CORAL, FL.,, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Community oncology practice Florida Oncology and Hematology, a partner practice of American Oncology Network (AON) (OTCQX: AONC), is pleased to announce patients now have another additional choice for medical oncology services in Lee County due to its continued expansion in Florida with the opening of its new location in Cape Coral where Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now accepting patients. The new Cape Coral clinic – located at 326 Del Prado Blvd, Suite 301 – offers Cape Coral-area patients further opportunity to choose a community oncology care practice that best suits their unique needs.

Florida Oncology and Hematology’s Cape Coral location is equipped to deliver the latest cancer care and therapies. As a partner practice of AON, Florida Oncology and Hematology offers an on-site infusion room, in-house lab and pathology services, access to an in-house specialty pharmacy for oral oncolytics, and support with care coordination and financial counseling, among other benefits.

“We are pleased to welcome Drs. Van den Bergh, Parsa, and Mann to Florida Oncology and Hematology and American Oncology Network,” said AON’s chief executive officer Todd Schonherz. “This new clinic, coupled with the addition of these three doctors who all have impressive backgrounds with years of experience providing quality, patient-centered care in Lee County communities, allows Cape Coral-area cancer patients the autonomy to tailor their care delivery as best suits their individual needs, which dovetails with AON’s core value of patient-centered care. We look forward to the expertise they bring to the AON team.”

Dr. Van den Bergh, who also practices at the new Florida Oncology and Hematology Fort Myers location, is the medical director at the Cape Coral practice, working alongside Dr. Parsa and Dr. Mann. Dr. Van den Bergh is triple Board-certified in internal medicine, oncology, and hematology. She earned her medical degree from American University of the Caribbean, completed an internship and residency in internal medicine at the University of Connecticut, and completed a fellowship in hematology-oncology at H. Lee Moffitt Cancer Center and Research Institute/University of South Florida where she was appointed chief fellow.

“I am excited to serve as medical director at Florida Oncology and Hematology’s Cape Coral location,” said Dr. Van den Bergh. “Florida Oncology and Hematology provides innovative and exceptional patient-centered care – the kind that I pride myself on delivering – so it was an easy decision to join in August when we opened the Fort Myers location where I am also seeing patients.”

Dr. Parsa is triple Board-certified in internal medicine, oncology, and hematology, and board eligible in palliative care. He earned his medical degree from the All India Institute of Medical Sciences, completed his residency in internal medicine at Michigan State University, and his fellowship in hematology and oncology at the Karmanos Cancer Center at Wayne State University.

“Joining Florida Oncology and Hematology is an opportunity to work with a team of innovative and exceptional patient-centered providers whose high standards align with my personal patient care goals,” said Dr. Parsa. “I am looking forward to collaborating with the talented physician team.”

Dr. Mann is triple Board-certified in internal medicine, oncology, and hematology. He earned his medical degree from Nova Southeastern University, completed his internal medicine residency at Lehigh Valley Health Network, and his fellowship in hematology and oncology at the University of Arizona, where he served as chief fellow.

“I am committed to ensuring cancer patients receive personalized, patient-centered care, and I believe a community-based approach is the best way to achieve that,” said Dr. Mann. “I am excited to join the physician team at Florida Oncology and Hematology because they are dedicated to providing the high standard of care that I pride myself in delivering each and every day.”

Florida Oncology and Hematology has opened four new practice locations since August 2024. The Florida Oncology and Hematology team now includes seven medical oncologists across five Florida locations, including the first Naples clinic that opened in August 2024, a Fort Myers clinic that opened in August 2024, and a second Naples clinic that opened in September 2024. The practice is committed to providing the communities it serves with innovative care for cancer and blood disorders that is delivered holistically based on research and evidence-based medicine. Florida Oncology and Hematology patients have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.

“On behalf of AON, I am thrilled to welcome Drs. Van den Bergh, Parsa, and Mann to Florida Oncology and Hematology and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “All three of these doctors have impressive backgrounds, and I am confident that our patients – and our team – will benefit immensely from their expertise and commitment to providing quality, patient-centered care in a community-based setting.”

Drs. Van den Bergh, Parsa, and Mann began accepting new patients at the Florida Oncology and Hematology Cape Coral clinic on October 21, 2024.

For more information about AON, visit AONcology.com. For more information about Florida Oncology and Hematology, visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Clearwater, Fort Myers, Naples, and Cape Coral, Florida. As a community-based practice, we offer a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.

Attachment


FAQ

When did Florida Oncology and Hematology open its new Cape Coral location?

Florida Oncology and Hematology opened its new Cape Coral location on October 21, 2024, with Drs. Van den Bergh, Parsa, and Mann beginning to accept new patients on that date.

Who are the new medical oncologists joining Florida Oncology and Hematology in Cape Coral?

The new medical oncologists joining Florida Oncology and Hematology in Cape Coral are Dr. Magali Van den Bergh (Medical Director), Dr. Venkata Parsa, and Dr. Shivtaj Mann. All three are board-certified in internal medicine, oncology, and hematology.

What services does the new Florida Oncology and Hematology location in Cape Coral offer?

The new Cape Coral location offers an on-site infusion room, in-house lab and pathology services, access to an in-house specialty pharmacy for oral oncolytics, and support with care coordination and financial counseling.

How many locations has Florida Oncology and Hematology opened since August 2024?

Florida Oncology and Hematology has opened four new practice locations since August 2024, bringing their total to five locations across Florida.

What is the stock symbol for American Oncology Network (AON)?

The stock symbol for American Oncology Network (AON) is AONC, traded on the OTCQX market.

AMER ONCOLOGY NETWORK A

OTC:AONC

AONC Rankings

AONC Latest News

AONC Stock Data

17.05M
13.05M
35.44%
0.16%
0.11%
Medical Care Facilities
Services-health Services
Link
United States of America
FORT MYERS